Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a personal history of cervical cancer that includes a neuroendocrine component, including mixed tumours, specifically of the small cell, large cell, or undifferentiated high-grade type.
- People at any stage — whether currently in treatment, being monitored after treatment, or experiencing a return of cancer — may be considered.
- People with any stage of disease may be considered.
- People who do not speak English may be considered if an interpreter provided by the institution is present during participation.
- People who have received or are currently receiving treatment at any hospital or cancer centre, not just MD Anderson Cancer Center, may be considered.
- People living in any country and of any ethnic background may be considered.
- People who wish to take part, including those who find out about the trial through the trial website, may be considered.
- Family members or legal representatives of a person who has passed away but had a history of neuroendocrine carcinoma of the cervix may also be considered for participation.
- Family members or legal representatives participating on behalf of a deceased patient must be able to read and speak English.
Who may not be able to join:
- People whose cervical cancer is of a neuroendocrine type known as a carcinoid tumour — either typical or atypical — may not be eligible for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Larissa A. Meyer, M.D. Anderson Cancer Center
Phone: 713-745-0973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease characterization data; Patient treatment data; Patient outcome data
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.